Lariago-DS Tablet

Lariago-DS Tablet belongs to the class of medications called 'quinoline' primarily used to treat malaria. Lariago-DS Tablet gives a degree of protection (prophylaxis) against malaria when people travel to areas where malarial cases exist. It is effective against Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. Lariago-DS Tablet is not effective against Plasmodium falciparum. Besides this, it also treats amoebiasis (intestinal dysentery) and rheumatic disease (arthritis). 

Lariago-DS Tablet contains 'chloroquine' which acts by killing the malarial parasites, i.e. Plasmodium and stops the formation of the nontoxic heme metabolite hemozoin by the parasite. Heme part of the red blood cells is broken by the malarial, causing parasites. Lariago-DS Tablet prevents the breakdown of heme part and is actually toxic to the parasite. It kills the parasitic form living in red blood cells that resides in the liver.

Lariago-DS Tablet should be taken as prescribed by your doctor. The dose of Lariago-DS Tablet can vary depending upon your condition and the severity of the infection. The common side effects of Lariago-DS Tablet include vomiting, nausea, hair loss and itchy skin. Everyone need not experience the above side effects. In case of any discomfort, speak with a doctor.

Before starting Lariago-DS Tablet, please inform your doctor if you are allergic to chloroquine or have kidney or liver problems. Do not take Lariago-DS Tablet on your own. Lariago-DS Tablet is safe to use during pregnancy and breastfeeding. Prolonged use of Lariago-DS Tablet may have a severe risk on the heart and retina of the eyes leading to pounding heartbeats and permanent vision problems. 

Lariago-DS Tablet falls into a group of medicines known as antimalarials, indicated for treating or preventing malaria. Lariago-DS Tablet contains chloroquine, which belongs to quinoline. It works by preventing the formation of the nontoxic heme metabolite hemozoin by the parasite. Due to this, the parasite dies from its own toxic by-products released due to haemoglobin's metabolism. Lariago-DS Tablet is also indicated for the treatment of rheumatoid arthritis and autoimmune diseases like lupus and intestinal infection caused by amoeba (amoebiasis).

Lariago-DS Tablet does not respond well against all malaria strains, so consult with your doctor if you do not respond well to Lariago-DS Tablet. This medicine can affect heart health, especially if a person is taking medications, including the antibiotic azithromycin and anticancer like tamoxifen. An individual must consult with the doctor if they are noticing fast or pounding heartbeats and sudden dizziness. This medicine cannot be used for a long duration as it may cause irreversible damage to the eye that could lead to vision problems. Lariago-DS Tablet cannot be used in persons who have heart disease, heart rhythm disorder, diabetes, a stomach disorder, an allergy to quinine, liver or kidney disease, psoriasis, alcoholism, porphyria (a genetic enzyme disorder that affects the skin or nervous system), a genetic enzyme deficiency called glucose-6-phosphate dehydrogenase (G6PD) deficiency. Consult with your doctor if you are pregnant or breastfeeding as this medicine could only be used if prescribed by the doctor. 

Do not take Lariago-DS Tablet if you have had a previous reaction to Lariago-DS Tablet, or if you have certain eye problems involving your retina. Tell your healthcare provider about any problems you may have with your eyes.